Related Experiment Video
Updated: Apr 10, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
Ioannis Alagkiozidis1, Melissa Lozano1, Mithun Devraj1
1Department of Gynecologic Oncology, SUNY-Downstate Medical Center, Brooklyn, NY, USA.
Abstract:
•We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab.•Targeting angiogenesis can provide disease control in patients with advanced uterine cancer.•Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Drugs that Stabilize Microtubules
Treatment Resistent Cancers
Treatment Resistant Cancers
Drugs that Destabilize Microtubules